We are live on ! Find out more
VAXX

Vaxxinity, Inc. Class A Common Stock
VAXX

Delisted

VAXX was delisted on the 8th of May, 2024.

Back to rankings

1 hedge funds and large institutions have $1.42K invested in Vaxxinity, Inc. Class A Common Stock in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CA
Crossingbridge Advisors
New York
+$1.42K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CA
1
Crossingbridge Advisors
New York
$1.42K +$1.42K +1,418 New

VAXX Hedge Fund Activity: Q1 2025 in Review

1 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q1 2025, worth a combined $1.42K.

Buyers outnumbered sellers: 1 fund opened new VAXX positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Crossingbridge Advisors, opening a new position worth an estimated $1.42K.

  • 1 institutional investor held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q1 2025, up from 0 in Q4 2024.
  • Funds reported $1.42K of Vaxxinity, Inc. Class A Common Stock stock for Q1 2025.
  • 1 fund opened new Vaxxinity, Inc. Class A Common Stock positions in Q1 2025 and 0 closed out, a net change of +1 holder.
  • The largest Vaxxinity, Inc. Class A Common Stock buyer in Q1 2025 was Crossingbridge Advisors, an estimated $1.42K added.

Based on aggregated 13F filings for Q1 2025.